that was the original technology that led to the partnership with kronos.phd from m.i.t. so i know you can explain this in layman's terms. if marijuana gives you the not dos, you can make it that. how you do that? or if it doesn't smell great for a lot of people. if you think about what you are getting when you are taking the entire flower from the plant, you are getting all kinds of things in there. some of them don't smoke it or make you hungry. there are only a few and with kronos we have a list of eight key ingredients like thc or cbd. there are others that are known to have positive effects. psychotropic or medicinal. is an example. ingredients that if you make them in isolation, you can get what you want without the stuff you don't. this is why you see a lot of interest in this around things like beverages and edibles and when you are not elon musk doins it. people see that as the future more than the technology. this type of approach is that we can make it. smoking even though it is legal in california has a stigma around it. what are the issues, how

there are only a few and with kronos we have a list of eight key ingredients like thc or cbd.ers that are known to have positive effects. psychotropic or medicinal. cbd oil is an example. those are ingredients that if you make them in isolation, you can get what you want without the stuff you don't. this is why you see a lot of interest in this around things like beverages and edibles and when you are not elon musk doing it. people see that as the future more than the technology. this type of approach is that we can make it. >> elon musk smoking even though it is legal in california has a stigma around it. what are the issues, how will it impact you? >> this is a key question. if you look at the story around steve jobs. he talked a lot about using recreational drugs and them having positive effects for him. it is legal technology. even in the tech industry there has been a history around the stuff. at the same time, there is a stigma seceded with it. after seeing it becoming legalized, people are recognizing what are the other options. alcohol is a popular recreational drug. i

let's take a look at canopy and kronos.f the best-performing stocks since it had its ipo back in july and kronos is up about 69% during that time. canopy is also doubled during the same time. it is not just the actions in the stoxx itself. we see volume go up in the options market and options on tilray talk about volume alone. looking at the other stocks, a lot of folks are moving into the space to get a piece of action whether it is betting on the stoxx to all up or down. when -- stocks to go up or down. we are seeing its much more weighted to the put side. people are looking at the valuation on the stoxx and saying they have gotten out of control. you have companies like tell ray -- tilray up in the valuation of something like 5 billion and 2 billion for renault's and revenue is still only $10 .illion per quarter it's based on the promise of what they will earn in revenue, not necessarily what they make now. we will toss to julie. >> i'm julie hyman and i popped appeared to continue to talk about the cannabis conversation

in the 1952 film long jeans kronos group watch away weekend next weekend on c-span book tv and american history tv. weekend on thei free c-span radio app. we are featuring the honolulu mayor. tonight on railamerica, historians edward l'engle and julie same join us to explain the 1990 film the lost battalion about world war i battles along the western front in france. here's a preview. >> have significant was it that this was filmed in france? the budget of this silent film? >> very significant. it would have also gone a great way towards increasing the audience.r the you have the real heroes of the battle in the real place where the battle took place so that would have an something for the audience. it would have been very powerful. couldroduction company have used that in their marketing materials explaining how realistic the film is. that would have potentially gotten people into the theaters to see it. >> compare the german soldier versus the french british american soldier in terms of preparation training. germans were highly trained. they were veterans. they had been fighting for f

have the cosmetic industry that still needs to find some counterparts i'll still long canopy and kronos i think tilray is probably a buy again. >> gw pharma, i think we did a power pitch for that sucker a year or so ago why are you making a face? >> just 15 minutes ago we told you it was fast pitch and not power pitch. >> it's probably gotten a little ahead of itself. morgan stanley just resumed coverage this group is going up gw pharma is a name, slow and steady wins the race if you want to be in the game, this is the one, i think. >>> still ahead, it is the new face of media. the market getting a makeover as facebook and netflix enter the communications sector. we'll tell you what it means for your portfolio. >>> plus, check out this stock hittingits lowest level in a decade down more than 50% from its 52-week high can you guess what it is the answer when we return. your brain is an amazing thing. but as you get older, it naturally begins to change, causing a lack of sharpness, or even trouble with recall. thankfully, the breakthrough in prevagen helps your brain and actually improves

when we built kronos group, we came from the u.s.canada and saw in opportunity to be in a federal, legal environment. with the scalable part of a company, is the ip, and that ip can move everywhere. we have the ability to registered the trademark and patent. we not conducting business he legally but you can get that ip protection. nike's fiscal first quarter is coming in well ahead of expectations. we are seeing a significant uptick in growth, much more than the 10% anticipated. review is staying in line with expectations -- revenue is a staying in line with expectations. michael, we are looking at the company that is educating the markets like nike, how do you educate the market and analysts? you have naysayers, particularly the short-sellers out there. some have looked at your company and said they are worried about this. how do you focus on what fundamentals should be looked at? michael: there are a lot of different factors. it is not a five-minute conversation. bringing people into the facility, understanding the differentiation,

canopy, kill ray, and kronos. canopy in white here is now worth more than alcoa.t cap for a company that basically just grows weed in canada. kill ray, which is in green here, if you bought this stock in july, you've gotten superhigh returns since then. initialsix times the ipo value. what you're looking at in this chart is the options volume, and the reason i think it's fascinating is the question is, do you want to take a bet this will continue to rise? or d want to hedge yourself in case you have a monumental crash, the likes of which you seen with cryptocurrencies and the dot-com bubble in 2000? anna: matt, well that was excellent. i'm tempted by a tie but i understand the rules do not allow a tie. i'm going to go with dani, because i feel like she was doing very well as you didn't have the benefit of all the puns you had to fall back. you will mystify and of the day, i'm sure. it raises a longer-term question about whether stocks rebound from the weakness we've seen an equity today around the trade story. thanks for everybody on battle of the charts. you can

the 1924 silent film, the hawaiian islands, and the 19 52 film long jeans kronos go. watch hawaii weekend next andend on c-span, "looktv" american history tv. listen to hawaii weekend on the free c-span radio app app. >> nexxt on lectures in history, brandeis university professor abigail cooper talks about the right to vote, make contracts and choose where they work. her class is about 50 minutes. to freedomr: slavery revisited. radicals and roots. latin --talk about the of or relating to roots and the linkages between radicalism and roots. now butmost a clichÉ there is an incredible way of looking forward to some kind

. >> taking a look at a few cannabis names tilray, kronos, canopy surging higher for the week.nsidering a cbd infused beverage what can we expect next? the price action in tilray yesterday, is that helpful for your space or not? >> i think it's always help. for our space. it shines considerable light on the cannabis industry that more and more people are talking about so ultimately i definitely welcome this at the same time i think there are questions about kind of the frothiness of some of these stocks in the multiples they're trading at i think a big function of that is probably driven by retail investor demand with lack of alternative investment options. >> walk us to what you think our reasonable valuations based on the projected revenue base for the industry, say in canada alone, over the next few years. >> what are the reasonable valuations i think realistically canada is not where we're going to be focusing our attention down the line they've had a great opportunity to kind of be a first mover advantage with nationalizing -- legalizing cannabis at the national level so t

tilray, canopy growth and kronos group are the three most heavily weighted stocks, each has a 10% weightingotal portfolio. a key thing to keep in mind with volatile things like the cannabis ones and the ones tide to marijuana are technical factors like short covering or options-related expiration other activities could have a big effect on that price up or down a good idea to tread cautiously or seek the advice of a financial adviser before dipping your toes into these stocks. back over to you guys. >> interesting the commentary surrounding cannabis stocks is similar to what we saw in terms of bitcoin and carl had a good point on with our strategist, that this might say something about the markets when we see markets close to record highs, we're seeing people stretch for these higher-valued -- perceived to be high growth pockets. >> not just that, melissa. i've been listening to your conversations and conversations that i've had with other market participants as well has likened it not only to the cryptocurrency bitcoin and that phenomenon we saw over the peak period last winter but in some

. >> look, let's face it, they trades in the nasdaq cgc trades on the new york kronos these stocks are tilray has more funded capacity and is a very real player in the space as well. you don't fault them for this. it's a global company. some of the other guys are, too. look at valuations the sector trades at about 35 times 2020 not terribly cheap but on a funded capacity if you want to look at it on a revenue basis, look at which companies are there. what i would point to is those companies that have big market caps don't mean they have a robust balance sheet some of these folks may have to raise capital. investors need to be very aware of which companies need to go out there. let's face it, in some cases if you're on that board, if you're the leader of that company, it makes sense to raise capital at these valuations that's your currency i think they'll do that. >> should investors place a higher valuation on u.s. listed cannabis stocks? the thinking that u.s. institutional investors may be precluded in investing in canadian stocks? >> today, the move in the big three u.s. names i men

. >> kronos is another one.ree with david, i forgot what we were talking about talking about marijuana. i adisagree the cannabis industry is getting sea legs. some regulation appealing to cannabis company. a lot are still in the canada. but they're coming into the united states. this industry is one to watch. >> in 1999 people said same thing about internets. nasdaq took 15 years. >> still around. >> still around but investors lost a lot of money. stuart: check the big board. check it constantly because we're in record territory. the dow is up 230 points. 26,635 where we are. stocks in the news. comcast and fox settle or will settle their 35 billion-dollar takeover battle for sky. there will be a rare weaken auction. that will settle it. >>> rosy out look from the parent company of olive garden. that parent company is darden restaurants. there is dispute about olive garden and its italian ethnicity. ashley: real italian food, stuart. i say that for justin. stuart: darden restaurants is up three bucks at 121. jus